Curis Lifesciences Ltd Financial Statement
*All values are in Rs. Cr
No Data Available
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 49.13 | 35.58 | 35.42 |
| Operating Expenses Annual | 39.60 | 27.14 | 32.17 |
| Operating Profit Annual | 10.05 | 8.75 | 3.59 |
| Interest Annual | 1.11 | 0.85 | 1.33 |
| Depreciation | 0.67 | 0.68 | 0.73 |
| Net Profit Annual | 6.11 | 5.36 | 1.23 |
| Tax Annual | 2.16 | 1.86 | 0.31 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 49.13 |
| Operating Expenses Annual | 39.60 |
| Operating Profit Annual | 10.05 |
| Interest Annual | 1.11 |
| Depreciation | 0.67 |
| Net Profit Annual | 6.11 |
| Tax Annual | 2.16 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.42 | 0.15 | 0.11 |
| Cash Flow from Operations | -1.76 | 0.28 | 3.35 |
| Cash Flow from Investing | -0.02 | -0.06 | -0.55 |
| Cash Flow from Financing | 1.67 | 0.05 | -2.76 |
| Cash Flow at the End | 0.30 | 0.42 | 0.15 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.42 |
| Cash Flow from Operations | -1.76 |
| Cash Flow from Investing | -0.02 |
| Cash Flow from Financing | 1.67 |
| Cash Flow at the End | 0.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 20.46 | 24.47 | 10.16 |
| PBIT Margin (%) | 19.09 | 22.55 | 8.10 |
| PBT Margin (%) | 1.89 | -4.02 | 2.00 |
| Net PROFIT Margin (%) | 12.44 | 13.70 | 3.47 |
| Return On Networth / Equity (%) | 55.32 | 152.90 | 246 |
| Return On Networth /Employed (%) | 34.13 | 40.46 | 16.48 |
| Return On Assets (%) | 22.26 | 24.65 | 7.40 |
| Total Debt / Equity (X) | 1.48 | 5.38 | TBA |
| Asset Turnover Ratio (%) | 1.79 | 1.80 | 2.13 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 20.46 |
| PBIT Margin (%) | 19.09 |
| PBT Margin (%) | 1.89 |
| Net PROFIT Margin (%) | 12.44 |
| Return On Networth / Equity (%) | 55.32 |
| Return On Networth /Employed (%) | 34.13 |
| Return On Assets (%) | 22.26 |
| Total Debt / Equity (X) | 1.48 |
| Asset Turnover Ratio (%) | 1.79 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 10.99 | 11.59 | 12.20 |
| Total Current Assets Annual | 31.29 | 22.05 | 17.30 |
| Non Current Assets Annual | 11.24 | 11.77 | 12.37 |
| Total Shareholders Funds Annual | 16.23 | 5.68 | 0.32 |
| Total Assets Annual | 42.53 | 33.82 | 29.67 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 10.99 |
| Total Current Assets Annual | 31.29 |
| Non Current Assets Annual | 11.24 |
| Total Shareholders Funds Annual | 16.23 |
| Total Assets Annual | 42.53 |
EPS (INR)
Expected
24.00
Reported
24.00
Surprise
0.00%
